Microanatomic relationships between CD8+ cells and HIV-1-producing cells in human lymphoid tissue in vivo

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 5, 2003, Pages 469-476

  Folkvord, Joy M ^a   Anderson, Deborah M ^a,b   Arya, Jyoti ^a   MaWhinney, Samantha ^a   Connick, Elizabeth ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b ICON CLINICAL RESEARCH   (United States)

Author keywords

CD8+T lymphocytes; Cytotoxic T lymphocytes; HIV infections; Lymph nodes; Lymphoid tissue

Indexed keywords

CD3 ANTIGEN; VIRUS RNA;

ARTICLE; CELL AGGREGATION; CELL KINETICS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FLOW CYTOMETRY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INGUINAL LYMPH NODE; LYMPHOID TISSUE; MALE; MOLECULAR RECOGNITION; PATHOLOGICAL ANATOMY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROCONVERSION; T LYMPHOCYTE; VIRUS REPLICATION;

CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOID TISSUE; MALE; RNA, VIRAL;

EID: 0345269687     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200304150-00001     Document Type: Article

References (39)

1. Trapani JA, Davis J, Sutton VR, et al. Propapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo. Curr Opin Immunol 2000;12:323-329.
2. Hartshorn K, Neumeyer D, Vogt M, et al. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. AIDS Res Hum Retroviruses 1987;3:125-133.
3. Cocchi F, DeVico AL, Garzino-Demo A, et al. Identification of RANTES, MIP-1 alpha, MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells, Science 1995;270:1811-1815.
4. Zhang L, Yu W, He T, et al. Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 2002;298:995-1000.
5. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68:4650-4655.
6. Borrow P, Lewicki H, Hahn BH, et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-6110.
7. Jin X, Bauer DE, Tuttleton SE, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999;189:991-998.
8. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999;283:857-860.
9. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-362.
10. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-358.
11. Schacker T, Little S, Connick E, et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis 2001;183:555-562.
12. Tamalet C, Lafeuillade A, Fantini J, et al. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during fourdrug combination therapy. AIDS 1997;11:895-901.
13. Sinicco A, Palestro G, Caramello P, et al. Acute HIV-1 infection: clinical and biologic study of 12 patients. J Acquir Immune Defic Syndr 1990;3:260-265.
14. Wood GS, Burns BF, Dorfman RF, et al. In situ quantitation of lymph node helper, suppressor, and cytotoxic T cell subsets in AIDS. Blood 1986;67:596-603.
15. Garcia CF, Lifson JD, Engleman EG, et al. The immunohistology of the persistent generalized lymphadenopathy syndrome (PGL). Am J Clin Pathol 1986;86:706-715.
16. Brask S, Hager H, Pallesen G, et al. Quantification of CD8-positive lymphocytes in lymph node follicles from HIV-infected male homosexuals and controls. Acta Pathol Microbiol Immunol Scand 1987;95:155-157.
17. Tedla N, Dwyer J, Truskett P, et al. Phenotypic and functional characterization of lymphocytes derived from normal and HIV-1-infected human lymph nodes. Clin Exp Immunol 1999;117:92-99.
18. Altman JD, Moss PAH, Goulder PJR, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996;274:94-96.
19. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998;279:2103-2106.
20. Gray CM, Lawrence J, Schapiro JM, et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART). J Immunol 1999; 162:1780-1788.
21. Wilson JDK, Ogg GS, Allen RL, et al. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS 2000;14:225-233.
22. Scott-Algara D, Buseyne F, Blanche S, et al. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers. J Infect Dis 2001;183:1565-1573.
23. McFarland EJ, Harding PA, Striebich CC, et al. Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected children. J Infect Dis 2002;186:477-485.
24. Altfeld M, van Lunzen J, Frahm N, et al. Expansion of preexisting, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection. J Clin Invest 2002;109:837-843.
25. Karr LJ, Panoskaltsis-Mortari A, Li J, et al. In situ hybridization for cytokine mRNA with digoxigenin-labeled riboprobes. Sensitivity of detection and double label applications. J Immunol Methods 1995;182:93-106.
26. Hockett RD, Kilby JM, Derdeyn CA, et al. Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med 1999;189:1545-1554.
27. Schacker T, Collier AC, Hughes J, et al. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125:257-264.
28. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42-48.
29. Haase AT, Henry K, Zupancic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996;274:985-989.
30. Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003;77:2081-2092.
31. Ohshima K, Suzumiya J, Sugihara M, et al. CD95 (Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes: a possible mechanism of immune evasion in chronic active EBV infection. Pathol Int 1999;49:9-13.
32. Rich RF, Green WR. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells. J Immunol 2002;168:2751-2758.
33. Collins KL, Chen BK, Kalams SA, et al. HIV-1 nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998;391:397-401.
34. Brodie SJ, Lewinsohn DA, Patterson BK, et al. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nat Med 1999;5:34-41.
35. Andersson J, Behbahani H, Lieberman J, et al. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissues during chronic HIV infection. AIDS 1999;13:1295-1303.
36. Appay V, Nixon DF, Donahoe SM, et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000;192:63-75.
37. Trimble LA, Shankar P, Patterson M, et al. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation. J Virol 2000;74:7320-7330.
38. Mothe BR, Horton H, Carter DK, et al. Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection. J Virol 2002;76:875-884.
39. Miller MJ, Wei SH, Parker I, et al. Two-photon imaging of lymphocyte motility and antigen response in intact lymph node. Science 2002;296:1869.